Letters in Drug Design & Discovery
Volume 18, 12 Issues, 2021
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Contents
Letters in Drug Design & Discovery, Volume 1 - Number 3
Entry Inhibitors - A New Class of Aids Drugs
, 1(3): 184 - 193Marcus Vinicius Nora De Souza
DOI: 10.2174/1570180043398786
First Inhibitors of the Steroidogenic Enzyme Type 7 17β-Hydroxysteroid Dehydrogenase
, 1(3): 194 - 197E. Bellavance, V. Luu-The and D. Poirier
DOI: 10.2174/1570180043398867
Cytotoxicity of 5H-Dibenzo[c,h][1,6]naphthyridin-6-ones and 6H-Indeno[1,2-c]isoquinolin-5,11-diones in Tumor Cells Sensitive and Resistant to Camptothecin Analogs
, 1(3): 198 - 202Alexander L. Ruchelman, Sudhir K. Singh, Angela Liu, Nai Zhou, Leroy F. Liu and Edmond J. La Voie
DOI: 10.2174/1570180043399064
Peptide Based Vaccine Design for Cancer Immunotherapy
, 1(3): 203 - 210D. S. Pouniotis, J. Halton and V. Apostolopoulos
DOI: 10.2174/1570180043398894
Chemogenomic Investigation of AP-1 Transcriptional Regulation of LTC4 Synthase Expression
, 1(3): 211 - 216Tiana Chong, Michael McMillan, Jia Ling Teo, William R. Henderson Jr. and Michael Kahn
DOI: 10.2174/1570180043398920
Advanced Pharmacophore Model of Non-Competitive AMPA Antagonist 2,3-benzodiazepines
, 1(3): 217 - 223B. Rezessy and S. Solyom
DOI: 10.2174/1570180043398948
Armed Imidazo [1,2-a] Pyrimidines (Pyridines): Evaluation of Antibacterial Activity
, 1(3): 224 - 229A. Anaflous, N. Benchat, M. Mimouni, S. Abouricha, T. Ben-Hadda, B. El-Bali, A. Hakkou and B. Hacht
DOI: 10.2174/1570180043398885
Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
, 1(3): 237 - 246Markus Kubicek, Silvia M. Sanz-Gonzalez, Francisco Verdeguer and Vicente Andres
DOI: 10.2174/1570180043398975
Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate
, 1(3): 247 - 255P. S. Cogan, C. R. Fowler, G. C. Post and T. H. Koch
DOI: 10.2174/1570180043399000
New Drug Design for Gene Therapy - Taking Advantage of Introns
, 1(3): 256 - 262Shi-Lung Lin and Shao-Yao Ying
DOI: 10.2174/1570180043398939
Apoptosis Signaling Pathways as Therapeutic Targets in Lung Injury
, 1(3): 263 - 268Kazuyoshi Kuwano, Naoki Hagimoto, Michihiro Yoshimi, Takashige Maeyama and Yoichi Nakanishi
DOI: 10.2174/1570180043398849
Atorvastatin Therapy Increases Monocyte / Macrophage Paraoxonase 2 Expression and Reduces Oxidative Stress in Hyprecholesterolemic Patients
, 1(3): 269 - 274Rosenblat Mira, Hayek Tony, Hussein Khetam and Michael Aviram
DOI: 10.2174/1570180043399046
A Stereospecific Route for the Preparation of Trans-Combretastatin Analogs: Synthesis and Cytotoxicity
, 1(3): 275 - 278Hari Pati, Zarmeen Taherbhai, Lori Forrest, Martha Wicks, Suzanna Bailey, Andrew Staples, Michelle Stewart, William Pennington, Jeffrey Harris and Moses Lee
DOI: 10.2174/1570180043398821
Prevention of Cell Damage in Ischaemic-Reperfusion: Mitochondrial Respiratory Chain as a Pharmacological Target
, 1(3): 279 - 284D. Morin, R. Zini, J. P. Tillement and A. Berdeaux
DOI: 10.2174/1570180043398803
Amide Mono Thioxylated Derivatives of MEN 10627
, 1(3): 285 - 288M. Altamura, G. Balacco, A. Giolitti, A. Guidi, R. Patacchini, A. R. Renzetti, A. Triolo and C. A. Maggi
DOI: 10.2174/1570180043398966
Rabies Vaccines: The Third Generation
, 1(3): 289 - 292T. Vanniasinkam and H. C. J. Ertl
DOI: 10.2174/1570180043398911
Editor-in-Chief
Ivana Cacciatore
Department of Pharmacy
University "G. d'Annunzio" of Chieti-Pescara
Chieti Scalo
(Italy)
Biography
Department of Pharmacy
University "G. d'Annunzio" of Chieti-Pescara
Chieti Scalo
Biography
Biography of Ivana Cacciatore
Prof. Ivana Cacciatore received her master’s degree in Pharmaceutical Chemistry and Technology in 1999 from the University of Chieti-Pescara (Italy). In 2002 she obtained her Ph.D. in Pharmaceutical Science. Currently, she is Associate Professor of Medicinal Chemistry at the Department of Pharmacy, University of Chieti-Pescara.
She is co-founder and member of the Board of Directors of the Spin Off Company "Algo Biotechnologies" holding the role of Chief Innovation Officer (CIO). Her research interests are drug design and discovery, medicinal chemistry, pharmacology, etc. Her research is well documented in more than 90 papers published in peer-reviewed international scientific Journals.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net